Ending the HIV Epidemic by 2020: Are We on Track?
Demetre C. Daskalakis, MD, MPH
Deputy Commissioner, Disease Control
NYC Department of Health and Mental Hygiene (DOHMH)
New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2018. All rights reserved.
Demetre Daskalakis is the Deputy Commissioner for the Division of Disease Control of the NYC Department of Health and Mental Hygiene. He received his medical education from NYU School of Medicine and completed his residency training in 2003 at Beth Israel Deaconess Medical Center in Boston. He also completed Clinical Infectious Disease fellowships at the Brigham and Women’s | Massachusetts General Hospital combined program. He received his Masters of Public Health from the Harvard School of Public Health. He has been a career-long physician activist in the area of HIV treatment and prevention among LGBT people. In his new role as Deputy Commissioner he oversees all infectious disease programs for New York City and the public health laboratory.
At the completion of this educational session, learners will:
- Be aware of epidemiology of HIV in NYC.
- Know more about New York City’s Ending the Epidemic Implementation Strategy and current progress of these strategic initiatives.
- Understand NYS HIV Status Neutral Treatment and Prevention framework for ending AIDS.
This CME activity was approved for
AMA PRA Category 1 Credit™ on February 13, 2018 and will terminate February 12, 2021.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Demetre Daskalakis (Presenter) has no relevant financial relationships to disclose. Dr. Daskalakis submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co; and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
